My watch list
my.bionity.com  
Login  

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris and in New York.

Sanofi Pasteur, the vaccines division of sanofi-aventis Group, provided more than a billion doses of vaccine in 2006, making it possible to immunize more than 500 million people across the globe. A world leader in the vaccine industry, Sanofi Pasteur offers the broadest range of vaccines protecting against 20 infectious diseases. The Company's heritage, to create vaccines that protect life, dates back more than a century. Sanofi Pasteur is the largest company entirely dedicated to vaccines. Every day, the company invests more than EUR1 million in research and development.

One of the world's leading pharmaceutical companies and number 1 in Europe.

Our major therapeutic areas : Cardiovascular, thrombosis, metabolic disorders, oncology, central nervous system, internal medicine and vaccines.

About 100,000 employees worldwide. Sales force of 35,000 medical visitors.

Present in 100 countries throughout the 5 continents. Consolidated sales of 28 billion euros and more than 4 billion euros Research & Development.

5,3% Market share.

More about Sanofi-Aventis
  • News

    Evotec receives € 3 million payment from Sanofi

    Evotec AG announced that its strategic alliance (TargetBCD) with Sanofi in the field of diabetes has reached its second beta cell therapy milestone, resulting in a payment of € 3 million to Evotec.  This milestone was triggered after Evotec met pre-agreed critical success criteria for a pot ... more

    Sanofi and Recipharm announce transfer of Holmes Chapel Manufacturing site

    Recipharm and Sanofi announced today that they have signed an agreement to transfer the Holmes Chapel site from global healthcare leader, Sanofi, to leading pharmaceutical contract development and manufacturing organisation, Recipharm. “Holmes Chapel brings Recipharm an ideal opportunity to ... more

    Sanofi will get new Head of Global R&D

    Elias Zerhouni, M.D., Head of Global Research and Development will retire from Sanofi on June 30th, 2018, after more than 9 years of distinguished service with the company. He will be succeeded in the post by John C. Reed, M.D. Ph.D. who has been appointed Head of Global Research & Developm ... more

  • Companies

    Sanofi-Aventis Deutschland GmbH

    Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris and in New York. Sanofi Pasteur, the vaccines division of sanofi-aventis Group, provided more than a billi ... more

    sanofi-aventis Groupe

    One of the world's leading pharmaceutical companies and number 1 in Europe. Sanofi-aventis' pharmaceuticals business focuses on six therapeutic areas: diabetes, oncology, thrombosis, cardiovascular diseases, central nervous system (CNS) and internal medicine. About 100,000 employees worl ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE